Coincidently, our quantitative analysis also showed a reduction of the G1 phase cell-cycle regulator, cyclin D1, and induction of p53/p27/p21 expression in these two stable GBM-Znf179 cell lines. The gene discussed is TP53; the disease is glioblastoma.